Procainamide

Uses & side effects

Product-specific side effects await source review.

Drug interactions

Antiarrhythmic medications in horses interact dangerously with sedatives, other cardiac drugs, and certain antibiotics, primarily risking fatal ventricular arrhythmias, profound cardiac depression, or toxic drug accumulation. Antiarrhythmics are most commonly used in horses to convert atrial fibrillation to normal sinus rhythm or to stabilize ventricular tachycardias. Because these drugs fundamentally alter the electrical pathways and ion channels of the equine heart, pairing them with other substances requires meticulous veterinary oversight.The most critical equine drug interactions for the primary classes of antiarrhythmics are outlined below:1. Quinidine (Class IA) InteractionsQuinidine sulfate is historically the drug of choice for treating atrial fibrillation in horses, but it has a narrow safety margin and severe interaction risks.Digoxin: Severe interaction. Concurrent administration of digoxin and quinidine significantly decreases the tissue clearance of digoxin and displaces it from plasma protein-binding sites. This triggers a rapid, dangerous spike in blood digoxin levels, frequently leading to fatal digitalis toxicity.Other QT-Prolonging Drugs: Antimicrobials like fluoroquinolones (e.g., enrofloxacin) and macrolides, or antifungals (e.g., itraconazole), drastically compound quinidine's electrical effects. Combining them causes excessive prolongation of the QT interval, putting the horse at high risk for torsades de pointes (a fatal ventricular arrhythmia).2. Lidocaine (Class IB) InteractionsLidocaine is commonly given to horses via intravenous continuous rate infusion (CRI) for ventricular arrhythmias, ileus, or systemic inflammation.Procainamide or Quinidine: High risk. Co-administering lidocaine with other Class I sodium-channel blockers creates additive cardiotoxic effects. This can depress cardiac conduction too severely, resulting in heart block, or overstimulate the central nervous system, leading to dangerous neurological tremors, excitation, or seizures.3. Sotalol and Amiodarone (Class III) InteractionsThese medications are increasingly used as oral or IV pre-treatments before transvenous electrical cardioversion (TVEC).Alpha-2 Agonists (Detomidine, Xylazine, Romifidine): Severe interaction. These common equine sedatives inherently slow down the heart rate and cause transient heart blocks. Stacking them with Class III antiarrhythmics severely depresses the heart's electrical output, potentially precipitating acute cardiac arrest or profound hypotension.General Anesthetics: Sotalol and amiodarone heavily prolong the ventricular repolarization (QT interval) in horses. Under general anesthesia (e.g., gas anesthetics like isoflurane), this prolongation is dangerously amplified, severely elevating the threat of malignant ventricular tachyarrhythmias during surgery.4. Potassium-Altering Medications (Diuretics)Medications: Furosemide (Salix/Lasix).The Interaction: Furosemide is heavily utilized in equine medicine to treat exercise-induced pulmonary hemorrhage (EIPH). However, it depletes potassium (hypokalemia).Clinical Impact: Nearly all antiarrhythmics—especially quinidine and sotalol—become exponentially more toxic and pro-arrhythmic when a horse’s blood potassium level drops, easily converting a stable rhythm into a lethal one.

Contraindications